Bills
H.R.5247

H.R.5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

Read the bill

About This Bill

This bill was introduced in the 115th Congress
This bill is primarily about health
Introduced March 13, 2018
Latest Major Action April 9, 2018

Bill Sponsor

Brian Fitzpatrick (R-Pa.)

Bill Cosponsors

44 (1 Democrat, 43 Republicans)

Bill Versions

Placed on Calendar Senate - April 9, 2018
Engrossed in House - March 21, 2018
Introduced in House - March 13, 2018

What Lawmakers Are Saying About This Bill

There are 27 statements associated with H.R.5247.

See statements

Bill Actions

Date	Description
April 9, 2018	Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 367.
March 23, 2018	Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
March 22, 2018	Received in the Senate.
March 21, 2018	Vote in the House On passage Passed by recorded vote: 267 - 149 (Roll no. 121).
March 21, 2018	Considered as unfinished business.
March 21, 2018	Mr. Pallone moved to recommit with instructions to the Committee on Energy and Commerce.
March 21, 2018	Considered under the provisions of rule H. Res. 787.
March 21, 2018	Vote in the House On passage Passed by recorded vote: 267 - 149 (Roll no. 121). (text: CR H1738-1739)
March 21, 2018	Considered as unfinished business. (consideration: CR H1748-1750)
March 21, 2018	Mr. Pallone moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H1746-1747)
March 21, 2018	Considered under the provisions of rule H. Res. 787. (consideration: CR H1738-1748)
March 21, 2018	Motion to reconsider laid on the table Agreed to without objection.
March 21, 2018	Vote in the House On motion to recommit with instructions Failed by the Yeas and Nays: 182 - 233 (Roll no. 120).
March 21, 2018	POSTPONED PROCEEDINGS - At the conclusion of debate on the Pallone motion to recommit with instructions, the Chair put the question on the motion and by voice vote announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays, and the Chair postponed further proceedings on the motion to recommit until later in the legislative day.
March 21, 2018	The previous question on the motion to recommit with instructions was ordered without objection.
March 21, 2018	DEBATE - The House proceeded with 10 minutes of debate on the Pallone motion to recommit with instructions. The instructions contained in the motion seek to report the same back to the House forthwith with an amendment to require the Food and Drug Administration (FDA) to issue guidance describing how the agency will use expanded access outcomes when considering and evaluating investigational products for full approval. Additionally, the motion seeks to provide liability protection to manufacturers, physicians, and hospitals offering a product under expanded access, as long as the entity is in compliance with current federal law, and it also increases transparency in the FDAs expanded access program.
March 21, 2018	The previous question was ordered pursuant to the rule.
March 21, 2018	DEBATE - The House proceeded with one hour of debate on H.R. 5247.
March 21, 2018	The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.
March 20, 2018	Rule H. Res. 787 passed House.
March 19, 2018	Rules Committee Resolution H. Res. 787 Reported to House. The resolution provides for one hour of debate on each bill. The resolutionmakes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H.Res. 5 by striking "the first
March 19, 2018	Rules Committee Resolution H. Res. 787 Reported to House. The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.
March 16, 2018	Referred to the Subcommittee on Health.
March 13, 2018	Considered as unfinished business.
March 13, 2018	Considered under suspension of the rules.
March 13, 2018	Vote in the House On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 259 - 140 (Roll no. 102).
March 13, 2018	At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
March 13, 2018	DEBATE - The House proceeded with forty minutes of debate on H.R. 5247.
March 13, 2018	Mr. Walden moved to suspend the rules and pass the bill.
March 13, 2018	Referred to the House Committee on Energy and Commerce.
March 13, 2018	Considered as unfinished business. (consideration: CR H1528-1529)
March 13, 2018	Considered under suspension of the rules. (consideration: CR H1521-1527; text of measure as introduced: CR H1521-1522)
March 13, 2018	Introduced in the House by Brian Fitzpatrick (R-Pa.)

Legislators

Bills

Statements

Lobbying

Travel

About This Bill

Bill Sponsor

Bill Cosponsors

Bill Versions

What Lawmakers Are Saying About This Bill

Vote in the House

Vote in the House

Vote in the House

Vote in the House

Introduced in the House by Brian Fitzpatrick (R-Pa.)